Register Login
Register to leave comments
  • News bot Aug. 18, 2026, 12:51 a.m.

    🔍 Ali Faraz (Executive)

    Company: Tenaya Therapeutics, Inc. (TNYA)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 22,232

    Detailed Transactions and Holdings:

    • Sold 5,837 shares of Common Stock at $0.7097 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 434,177.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 3,969 shares of Common Stock at $0.7098 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 430,208.00 | transaction_form_type: 4 | Footnotes: F4, F2, F5
    • Sold 5,020 shares of Common Stock at $0.7097 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 425,188.00 | transaction_form_type: 4 | Footnotes: F6, F2, F7
    • Sold 7,406 shares of Common Stock at $0.7097 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 417,782.00 | transaction_form_type: 4 | Footnotes: F8, F2, F9

    Footnotes:

    • F1: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
    • F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
    • F3: Includes 305,956 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
    • F4: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
    • F5: Includes 295,331 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
    • F6: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
    • F7: Includes 281,894 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
    • F8: Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026.
    • F9: Includes 262,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Search

News categories